SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-016174
Filing Date
2018-11-14
Accepted
2018-11-14 16:54:28
Documents
96
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1789480
2 ex31-1.htm EX-31.1 19627
3 ex31-2.htm EX-31.2 19604
4 ex32-1.htm EX-32.1 6957
5 ex32-2.htm EX-32.2 7181
  Complete submission text file 0001493152-18-016174.txt   7671154

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rnva-20180930.xml EX-101.INS 1224912
7 XBRL SCHEMA FILE rnva-20180930.xsd EX-101.SCH 90123
8 XBRL CALCULATION FILE rnva-20180930_cal.xml EX-101.CAL 83844
9 XBRL DEFINITION FILE rnva-20180930_def.xml EX-101.DEF 356774
10 XBRL LABEL FILE rnva-20180930_lab.xml EX-101.LAB 582458
11 XBRL PRESENTATION FILE rnva-20180930_pre.xml EX-101.PRE 472500
Mailing Address 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401
Business Address 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401 561-855-1626
Rennova Health, Inc. (Filer) CIK: 0000931059 (see all company filings)

IRS No.: 680370244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35141 | Film No.: 181184830
SIC: 8734 Services-Testing Laboratories
Assistant Director 9